Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life.

Autor: Peters M; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands. Electronic address: m.peters-10@umcutrecht.nl., Maenhout M; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands. Electronic address: M.maenhout@umcutrecht.nl., van der Voort van Zyp JR; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands., Moerland MA; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands., Moman MR; Department of Radiology, Meander Medical Center, Amersfoort, The Netherlands., Steuten LM; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands., van Deursen MJ; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands., van Vulpen M; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2014 Jul; Vol. 112 (1), pp. 77-82. Date of Electronic Publication: 2014 Jul 03.

Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants.

Autor: Moerland MA; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands. m.a.moerland@umcutrecht.nl, van Deursen MJ, Elias SG, van Vulpen M, Jürgenliemk-Schulz IM, Battermann JJ

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2009 May; Vol. 91 (2), pp. 202-6. Date of Electronic Publication: 2008 Oct 22.